Use of Long-Acting Injectables in Borderline Personality Disorder: What Do We Know?

被引：0
|
作者：
Almeida, E. D. S. [1 ]
Abreu, J. [1 ]
Vaz, R. P. [1 ]
Martins, J. [1 ]
Cunha, F. [1 ]
Santos, I. [1 ]
Castro, N. [1 ]
Andrade, R. P. [1 ]
Monteiro, E. [1 ]
机构：
[1] Ctr Hosp Tondela Viseu, Viseu, Portugal
来源：
EUROPEAN PSYCHIATRY | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0048
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [1] Effectiveness of long-acting paliperidone palmitate in borderline personality disorder
    Palomares, Nerea
    Montes, Ana
    Diaz-Marsa, Marina
    Carrasco, Jose L.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (06) : 338 - 341
  • [2] What role do long-acting injectables (LAIs) have in the treatment of schizophrenia?
    Schreiner, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S632 - S632
  • [3] Long-acting antipsychotics: is what we know really so?
    Cosgrove, Lisa
    Mintzes, Barbara
    Bursztajn, Harold J.
    Shaughnessy, Allen F.
    LANCET PSYCHIATRY, 2021, 8 (08): : 651 - 651
  • [4] The concurrent use of two long-acting injectables in the maintenance treatment of bipolar disorder
    Koh, Li-Ying Charlotte
    Chandwani, Nisha
    Lim, Shuli
    Chan, Christopher Yi Wen
    BIPOLAR DISORDERS, 2021, 23 (03) : 312 - 314
  • [5] Long-Acting Aripiprazole in Comorbid Bipolar Disorder and Borderline Personality Disorder and Substance Abuse
    Salomon Martinez, Jesus
    Sanchez Caballero, Asur Rahuel
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (02) : 266 - 267
  • [6] What do we know about borderline personality disorder? Current aspects of etiology, diagnostics and treatment
    Stoffers-Winterling, Jutta
    Krause-Utz, Annegret
    Lieb, Klaus
    Bohus, Martin
    NERVENARZT, 2021, 92 (07): : 643 - 652
  • [7] Borderline personality disorder: What do we know? Diagnosis, course, co-morbidity, and aetiology
    Cartwright, Duncan
    SOUTH AFRICAN JOURNAL OF PSYCHOLOGY, 2008, 38 (02) : 429 - 446
  • [8] What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?
    Samalin, Ludovic
    Nourry, Aurore
    Charpeaud, Thomas
    Llorca, Pierre-Michel
    NORDIC JOURNAL OF PSYCHIATRY, 2014, 68 (04) : 227 - 235
  • [9] Long-Acting Ocular Injectables: Are We Looking In The Right Direction?
    Dang, Mickael
    Shoichet, Molly S.
    ADVANCED SCIENCE, 2024, 11 (08)
  • [10] Long-Acting Injectables: A Strategy to Mitigate Nonadherence in Bipolar Disorder
    Faden, Justin
    Maymind, Elina
    BIPOLAR DISORDERS, 2025,
12345